FDA greenlights Bigfoot Biomedical ' s insulin recommending diabetes management system

The system was cleared for use among individuals 12 years old and up with Type 1 or Type 2 diabetes on multiple-dose injection therapy.  
Source: mobihealthnews - Category: Information Technology Source Type: news